Sirawat Srichatrapimuk

Bangkok, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Persistent IP-10/CXCL10 dysregulation following mild Omicron breakthrough infection: Immune network signatures across COVID-19 waves and implications for mRNA vaccine outcomes.

Persistent IP-10/CXCL10 dysregulation following mild Omicron breakthrough infection: Immune network signatures across COVID-19 waves and implications for mRNA vaccine outcomes.

Journal: Clinical immunology (Orlando, Fla.)

Published: January 09, 2025

A comparative study between methylprednisolone versus dexamethasone as an initial anti-inflammatory treatment of moderate COVID-19 pneumonia: an open-label randomized controlled trial.

A comparative study between methylprednisolone versus dexamethasone as an initial anti-inflammatory treatment of moderate COVID-19 pneumonia: an open-label randomized controlled trial.

Journal: BMC pulmonary medicine

Published: May 22, 2024

Molnupiravir versus favipiravir in at-risk outpatients with COVID-19: A randomized controlled trial in Thailand.

Molnupiravir versus favipiravir in at-risk outpatients with COVID-19: A randomized controlled trial in Thailand.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: November 07, 2023

Prevalence and risk factors of cytomegalovirus reactivation in critically Ill patients with COVID-19 pneumonia.

Prevalence and risk factors of cytomegalovirus reactivation in critically Ill patients with COVID-19 pneumonia.

Journal: PloS one

Published: February 08, 2023

Increased platelet activation and lower platelet-monocyte aggregates in COVID-19 patients with severe pneumonia.

Increased platelet activation and lower platelet-monocyte aggregates in COVID-19 patients with severe pneumonia.

Journal: PloS one

Published: September 09, 2022

Detectable Duration of Viable SARS-CoV-2, Total and Subgenomic SARS-CoV-2 RNA in Noncritically Ill COVID-19 Patients: a Prospective Cohort Study.

Detectable Duration of Viable SARS-CoV-2, Total and Subgenomic SARS-CoV-2 RNA in Noncritically Ill COVID-19 Patients: a Prospective Cohort Study.

Journal: Microbiology spectrum

Published: May 23, 2022

Effects of pitavastatin on atherosclerotic-associated inflammatory biomarkers in people living with HIV with dyslipidemia and receiving ritonavir-boosted atazanavir: a randomized, double-blind, crossover study.

Effects of pitavastatin on atherosclerotic-associated inflammatory biomarkers in people living with HIV with dyslipidemia and receiving ritonavir-boosted atazanavir: a randomized, double-blind, crossover study.

Journal: AIDS research and therapy

Published: April 14, 2022

Missed opportunities for earlier diagnosis of HIV infection in people living with HIV in Thailand.

Missed opportunities for earlier diagnosis of HIV infection in people living with HIV in Thailand.

Journal: PLOS global public health

Published: April 04, 2022

Spontaneous tension hemothorax in a severe COVID-19 patient receiving ECMO therapy: The other side of COVID-19-associated coagulopathy.

Spontaneous tension hemothorax in a severe COVID-19 patient receiving ECMO therapy: The other side of COVID-19-associated coagulopathy.

Journal: Respiratory medicine case reports

Published: January 09, 2022

Anti-HIV serological test algorithms to reduce false-positive and inconclusive results for low HIV prevalence and resource-limited areas.

Anti-HIV serological test algorithms to reduce false-positive and inconclusive results for low HIV prevalence and resource-limited areas.

Journal: International journal of STD & AIDS

Published: September 27, 2021

CoronaVac induces lower neutralising activity against variants of concern than natural infection.

CoronaVac induces lower neutralising activity against variants of concern than natural infection.

Journal: The Lancet. Infectious diseases

Published: July 08, 2021

SARS-CoV-2 neutralizing antibodies decline over one year and patients with severe COVID-19 pneumonia display a unique cytokine profile.

SARS-CoV-2 neutralizing antibodies decline over one year and patients with severe COVID-19 pneumonia display a unique cytokine profile.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: July 01, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026